Ms. Salazar (for herself, Ms. Pingree, Mr. Smith of New Jersey, Mr. Johnson of Georgia, Mr. Owens, Ms. Norton, Mrs. Kim, Mr. Rouzer, and Mr. Tonko) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend title XVIII of the Social Security Act to provide for coverage and payment of Alpha-1 Antitrypsin Deficiency Disorder treatment under part B of such title, and for other purposes.
Chellie Pingree
(ME); Christopher H. Smith
(NJ); Henry C. "Hank" Johnson, Jr.
(GA); Burgess Owens
(UT); Eleanor Holmes Norton
(DC); Young Kim
(CA); David Rouzer
(NC); Paul Tonko
(NY)
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. John W. Walsh Alpha-1 Home Infusion Act of 2025. H.R. 2343. 119th
Cong., 1st
sess., Introduced in House March 25, 2025. https://www.govinfo.gov/app/details/BILLS-119hr2343ih.
APA
Congress, House of Representatives (2025, March 25). John W. Walsh Alpha-1 Home Infusion Act of 2025 (H.R. 2343 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr2343ih.
MLA
United States, Congress, House of Representatives. John W. Walsh Alpha-1 Home Infusion Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr2343ih. 119th Congress, H.R. 2343, Introduced in House 25 Mar. 2025.
Bluebook
H.R.2343 - 119th Congress (2025-2026): John W. Walsh Alpha-1 Home Infusion Act of 2025, H.R.2343, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr2343ih.
